Chapter 40. Diabetes, Insulin Resistance and Glucose Metabolism in HIV Infection and its Treatment

  1. Dr Jean-Marie Ekoé Professor of Medicine Faculty of Medicine member recipient principal investigator co-investigator Chairman2,
  2. Dr Marian Rewers principal investigator Core director Program Chair Chair3,
  3. Rhys Williams Dean of Medicine Professor of Clinical Epidemiology chair Vice President Editor-in-Chief member visiting consultant4 and
  4. Paul Zimmet Director Hon. Professor Officer5
  1. Kathy Samaras and
  2. Don J. Chisholm

Published Online: 11 SEP 2008

DOI: 10.1002/9780470779750.ch40

The Epidemiology of Diabetes Mellitus, Second Edition

The Epidemiology of Diabetes Mellitus, Second Edition

How to Cite

Samaras, K. and Chisholm, D. J. (2008) Diabetes, Insulin Resistance and Glucose Metabolism in HIV Infection and its Treatment, in The Epidemiology of Diabetes Mellitus, Second Edition (eds J.-M. Ekoé, M. Rewers, R. Williams and P. Zimmet), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470779750.ch40

Editor Information

  1. 2

    Endocrinologie, Métabolisme et Nutrition, Centre de Recherche du CHUM, Montreal, Canada

  2. 3

    Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA

  3. 4

    Clinical Epidemiology at the School of Medicine, University of Swansea, Swansea, UK

  4. 5

    International Diabetes Institute Caulfield, Victoria, Australia

Author Information

  1. Diabetes and Obesity Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

Publication History

  1. Published Online: 11 SEP 2008
  2. Published Print: 19 SEP 2008

ISBN Information

Print ISBN: 9780470017272

Online ISBN: 9780470779750

SEARCH

Keywords:

  • HIV-1 infection and highly active antiretroviral therapy (HAART);
  • diabetes and HIV infection prevalence;
  • HIV-infected HAART hyperglycemia recipients;
  • mitochondrial dysfunction in insulin resistance;
  • nucleoside reverse-transcriptase inhibitors (NRTIs);
  • HIV-infected HAART recipients and lipoatrophy;
  • dyslipidemia and HAART metabolic complications

Summary

This chapter contains sections titled:

  • Introduction

  • Prevalence

  • Pathogenesis

  • Lipodystrophy Treatment Considerations

  • Summary

  • References